Product Information

NARATRIPTAN HCL 2.5 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $1.0722 per EA under NDC 69452034172. Its NADAC has been published 228 times since Jul 13, 2022.

FDA first approved this application on Apr 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NARATRIPTAN HCL 2.5 MG TABLET

Naratriptan
$1.0722per EA

Strength

2.5 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452034172

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NARATRIPTAN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA091441

FDA Approved

4/30/2012

TE Code

AB

On Market Since

4/11/2022

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for NARATRIPTAN HCL 2.5 MG TABLET has been published 228 times since Jul 13, 2022, and over the history we have for it it has declined 43.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0722 per EA
All-time high$1.8966 (Jul 13, 2022)
All-time low$0.8797 (Nov 20, 2024)
52-week high$1.1887
52-week low$1.0329
Median price$1.3106
Average price$1.2949
Largest weekly change+37.3% (Aug 21, 2024)
Weeks tracked228
Tracking sinceJul 13, 2022

Price History

1W

-2.8%

1M

-1.0%

3M

-7.6%

6M

+3.8%

1Y

-9.8%

3Y

-18.3%

5Y

N/A

All

-43.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NARATRIPTAN HCL 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NARATRIPTAN HCL 2.5 MG TABLET, manufactured by Bionpharma Inc., is $1.0722 per EA (NDC 69452034172), effective Nov 18, 2026.

How has the price of NARATRIPTAN HCL 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for NARATRIPTAN HCL 2.5 MG TABLET has declined 43.5%. It has been tracked across 228 weekly CMS publications since Jul 13, 2022.

What are the highest and lowest recorded NADAC prices for NARATRIPTAN HCL 2.5 MG TABLET?

Since Jul 13, 2022, the NADAC for NARATRIPTAN HCL 2.5 MG TABLET has ranged from a low of $0.8797 (Nov 20, 2024) to a high of $1.8966 (Jul 13, 2022), with a median of $1.3106 per EA.

Are there cheaper alternatives to NARATRIPTAN HCL 2.5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NARATRIPTAN HCL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures NARATRIPTAN HCL 2.5 MG TABLET?

NARATRIPTAN HCL 2.5 MG TABLET (NDC 69452034172) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.